BioNovo, Inc. (fka BNVIQ)

[piano benchpress]

I concur. Sounds to me from the cursory read of their filed documents today that this is another dilution. When this hit .38 I was long since out. I don't see anything in their pipeline that is even close to a phase III trial. Please correct me if this statement is inaccurate. IMO there are plenty of other biotechs with more promise where one can put one's funds in lieu of having them languish. Very disappointing. If this retreats more, as I think it will, I will find another point to reenter. Until then - GLTA to all BNVI longs.

This is not an endorsement to either buy or sell BNVI as should not be construed as such. It is my opinion only.